Five Kilometers, 3.11 Miles, and $250,000 for Cancer Science: Running for Research at the AACR Annual Meeting
A few AACR Runners for Research shared their thoughts as they prepare to pound some pavement and raise money...
A few AACR Runners for Research shared their thoughts as they prepare to pound some pavement and raise money...
Learn how liquid biopsy could be used to detect cancer and guide treatment as researchers work to develop more...
Highlights from a roundtable featuring cancer survivors and researchers discussing cancer disparities and persistent health inequities.
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's on the...
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
Highlights from Cancer Today's summer 2024 issue, including treatment-induced heart conditions, profile of Brian Jones, and more.
Learn about the types of cancer immunotherapy including immune checkpoint inhibitors, ACT, therapeutic vaccines, and more.
LGBTQ+ cancer survivors offer lessons learned, and a researcher explains the odds of chronic conditions in LGBTQ+ survivors.
At a recent AACR Special Conference, experts discussed emerging therapeutic options to overcome resistance to Bacillus Calmette-Guérin (BCG).